Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation

Table 2

Main adverse events after transplant in the two study groups.

	Patients (𝑛=25)	Reference-patients (𝑛=50)
Acute rejections—𝑛 (%)	1 (4.0)*	13 (26.0)
DGF—𝑛 (%)	1 (4.0)	5 (10.0)
N. of dialyses	2	1 (1-2)
Leukopenia—𝑛 (%)	4 (16)	8 (16)
Thrombocytopenia—𝑛 (%)	0	1 (2)
CMV reactivations—𝑛 (%)	5 (20)*	27 (54.0)
CMV DNA	5/25 (20)	8/14 (57.1)
Ag PP65	—	19/36 (52.7)

Data are number (percentage) or median (range). DGF: delayed graft function, leukopenia: leukocytes < 3000/mm³, thrombocytopenia: platelets < 50,000/mm³, *𝑃<0.05 versus reference-patients.